SHARE

Germany, Innovation, 2018

European Health Catapult Finalist SpinDiag showcased on German TV

15th August 2019

Fighting drug-resistant bacteria in hospitals

SpinDiag, one of the finalists in the European Health Catapult 2017, supported by EIT Health, was recently featured in a German TV news show. SpinDiag addresses the challenge of patients who introduce drug-resistant bacteria into hospitals with a new, rapid point-of-care screening system to test all risk patients for all relevant drug-resistances.

This affordable solution allows doctors to make an informed decision the spot about whether a patient needs to be isolated from others.

The team has now been portrayed on German Television SWR in a report that can be seen here, starting at minute 11:45 in this news show. SpinDiag, a German-based firm, is currently hiring a finance/office manager. See the current job offers here.

More information about SpinDiag can be found here

Five Lives and Neurocast win the first ‘neurotechprize’

Five Lives and Neurocast win the first ‘neurotechprize’

Five Lives and Neurocast win Neurotechprize

Find out more

EIT Health-supported IMPLICITY raises €21M

EIT Health-supported IMPLICITY raises €21M

Funding will help international expansion and fuel AI-based medical algorithm development

Find out more

First annual Bits & Pretzels HealthTech announced

First annual Bits & Pretzels HealthTech announced

EIT Health and Roche are founding partners

Find out more